Home›People›Sundeep Agrawal
SA

Sundeep Agrawal

Director at BlossomHill Therapeutics.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 10, 2026·Suggest an edit

About Sundeep Agrawal

Sundeep Agrawal is a director at BlossomHill Therapeutics.

Sundeep Agrawal reports to the SEC as a director of 3 public companies, including PAVmed (PAVM) and FoxWayne Enterprises Acquisition (FOXW).

Sundeep Agrawal first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Sundeep Agrawal in the role, so the role may have started earlier or lasted longer.

BlossomHill Therapeutics, Inc.
Director
2024 – 2026 · Public company (BLSM)
PAVmed Inc.
Director
2024 – 2026 · Public company (PAVM)
FoxWayne Enterprises Acquisition Corp.
Director
2021 · Public company (FOXW)

Key Colleagues at Startups

The people Sundeep Agrawal works with at each company, as listed on that company's latest Form D.

BlossomHill Therapeutics, Inc. · Form D, Dec 10, 2025
GL
George Lee
Director
CG
Carl Gordon
Director
YL
Yishan Li
Executive officer and director
BC
Bihua Chen
Director
TS
JC
Jingrong Jean Cui
President and Chief Executive Officer, director

Sources

  1. SECBlossomHill Therapeutics, Inc. Form D, filed Dec 10, 2025
  2. SECForms 3, 4 and 5 filed by Sundeep Agrawal (SEC filer 1840599)